Comparison of lactate dehydrogenase and hemoglobinA1C in patients with severechronic periodontitis before and after SRP

Comparison of salivary markers (lactate dehydrogenase and hemoglobinA1C) in patients with severe chronic periodontitis before and after phase one periodontal treatment

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180122038475N3

Enrollment

Registered

2020-06-15

Start date

2020-06-14

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic periodontitis. Chronic periodontitis

Interventions

Phase 1 Periodontal treatment:scaling and rootplaning.

Eligibility

Sex/Gender

All

Age

30 Years to 50 Years

Inclusion criteria

Inclusion criteria: People between 30 and 50 years old Non-pregnant and non-breastfeeding women Conscious consent of the patient There are at least 20 teeth in the mouth Severe chronic periodontitis The presence of a larger CAL is equal to 5 at least two teeth

Exclusion criteria

Exclusion criteria: Smoking and other tobacco products Taking effective over-the-counter medications Antibiotics have been used for the past 6 months previous periodontal treatment use corticosteroids Existence of systemic disease affecting periodontal conditions

Design outcomes

Primary

Measure	Time frame
Lactate dehydrogenase. Timepoint: Periodontal treatment before phase 1 and periodontal treatment 1 month after phase 1. Method of measurement: Laboratory tests of lactate dehydrogenase.;Hemoglobin A1c. Timepoint: Periodontal treatment before phase 1 and periodontal treatment 1 month after phase 1. Method of measurement: Hemoglobin A1c Laboratory Kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomaye Ansari Moghadam

Zahedan University of Medical Sciences

ansarimoghadam@zaums.ac.ir+98 54 3344 1824

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026